{{Rsnum
|rsid=2832077
|Chromosome=21
|position=28768699
|Orientation=plus
|GMAF=0.2493
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LOC102724420
|Gene_s=LOC102724420
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 28.3 | 67.3
| HCB | 16.9 | 52.9 | 30.1
| JPT | 12.4 | 47.8 | 39.8
| YRI | 2.7 | 18.5 | 78.8
| ASW | 1.8 | 14.0 | 84.2
| CHB | 16.9 | 52.9 | 30.1
| CHD | 26.2 | 49.5 | 24.3
| GIH | 7.9 | 34.7 | 57.4
| LWK | 1.8 | 15.5 | 82.7
| MEX | 3.5 | 33.3 | 63.2
| MKK | 2.6 | 25.3 | 72.1
| TSI | 6.9 | 31.4 | 61.8
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs2832077
|PubMedID=17903297
|Condition=Cognitive test performance
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PMID|17903297|OA=1
}} non sig. gwas, top 25 GEE p-values, measure of attention and executive function

{{PharmGKB
|RSID=rs2832077
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903297; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study (Initial Sample Size: 705 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Cognitive test performance.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356441
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2832077
|overall_frequency_n=17
|overall_frequency_d=128
|overall_frequency=0.132812
|n_genomes=16
|n_genomes_annotated=0
|n_haplomes=18
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}